ADVAIR HFA 21 ug/1 (Fluticasone Propionate and Salmeterol Xinafoate AEROSOL, METERED) 21 ug/1

ADVAIR HFA 21 ug/1 is a combination inhaler containing fluticasone propionate and salmeterol xinafoate. It is designed for respiratory use to help manage asthma and COPD symptoms. This metered aerosol provides precise dosing for effective respiratory support.

Strength

21 ug/1

Pack Size

1 INHALER in 1 CARTON (0173-0716-22) / 60 AEROSOL, METERED in 1 INHALER

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ADVAIR HFA 21 ug/1 is commonly used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The inhaler combines a corticosteroid and a long-acting beta-agonist to reduce inflammation and improve airflow in the lungs. It is often prescribed for individuals who require regular management of their respiratory conditions.

Side Effects

Users of ADVAIR HFA 21 ug/1 may experience improved breathing and reduced symptoms such as wheezing and shortness of breath. The medication works by decreasing inflammation in the airways and relaxing the muscles around the bronchial tubes. Some individuals may notice a decrease in the frequency and severity of asthma attacks or COPD exacerbations.

Precautions & Warnings

ADVAIR HFA 21 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Regular monitoring may be necessary to assess the effectiveness and safety of the treatment. Users should be aware of potential side effects and consult their healthcare provider if any concerns arise.

Avoid Interactions

ADVAIR HFA 21 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other respiratory depressants should be discussed with a healthcare professional.

Frequently Asked Questions

ADVAIR HFA 21 ug/1 is used for the maintenance treatment of asthma and COPD to reduce inflammation and improve airflow in the lungs.

ADVAIR HFA 21 ug/1 is administered via inhalation using the provided metered aerosol inhaler. Follow the instructions provided by your healthcare professional for proper use.

Common side effects may include throat irritation, hoarseness, and headaches. Users should consult their healthcare provider if they experience any severe or persistent side effects.

ADVAIR HFA 21 ug/1 may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

ADVAIR HFA 21 ug/1 is not suitable for everyone. It should be used under the guidance of a healthcare professional who can assess its appropriateness based on individual health conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.